Recon: FDA approves Iovance’s cell therapy Amtagvi for solid tumors; Pfizer’s inflammatory bowel disease drug authorized in EU
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States